Aclarion, Inc. develops healthcare technology for chronic low back pain care, with news centered on Nociscan, its software-as-a-service platform that uses magnetic resonance spectroscopy data, proprietary signal processing, biomarkers and augmented intelligence algorithms to help physicians distinguish painful from nonpainful lumbar discs.
Company updates commonly address commercial adoption, clinical-site agreements, physician education, AI-enabled clinical decision support, shareholder communications, investor-conference participation and governance actions such as a stockholder rights plan. Aclarion also reports through Nasdaq-traded common stock and warrants under ACON and ACONW.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.